<DOC>
	<DOCNO>NCT00073853</DOCNO>
	<brief_summary>Autologous Incubated Macrophages ( ProCord ) develop therapy acute , complete spinal cord injury ( SCI ) . The therapy intend reverse loss motor sensory function . Following non-CNS tissue injury , macrophage quickly arrive scene , clean cell debris , secrete different molecule thus promote control inflammatory reaction form first phase wound heal process . While process occur tissue , include peripheral nerve , occur CNS , macrophages immune cell relatively rare , activity curtail biochemical mechanism know `` immune privilege . '' In animal study , appear incubated macrophage circumvent immune privilege , thus support regrowth axon injury site enable recovery neurological function . The concept derive pioneer research Prof. Michal Schwartz Weizmann Institute Science .</brief_summary>
	<brief_title>Autologous Incubated Macrophages Patients With Complete Spinal Cord Injuries</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Traumatic SCI last 14 day Age 16 65 year Complete spinal cord injury ( ASIA A ) Neurological level : C5 T11 MRI show lesion Women pregnant breastfeeding Coma severe injury disease Penetrating injury Ongoing mechanical ventilation Unsuitable base MRI factor</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>paraplegia</keyword>
	<keyword>quadraplegia</keyword>
	<keyword>tetraplegia</keyword>
	<keyword>paralysis</keyword>
	<keyword>nerve regeneration</keyword>
	<keyword>Acute , Complete SCI</keyword>
</DOC>